Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, October 2003, p. 3073-3079, Vol. 47, No. 10
0066-4804/03/$08.00+0 DOI: 10.1128/AAC.47.10.3073-3079.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Antimony Uptake Systems in the Protozoan Parasite Leishmania and Accumulation Differences in Antimony-Resistant Parasites
Christian Brochu,1 Jingyu Wang,2 Gaétan Roy,1 Nadine Messier,1 Xiao-Yan Wang,2 Nancy G. Saravia,3 and Marc Ouellette1*
Centre de Recherche en Infectiologie du Centre de Recherche du CHUL and Division de Microbiologie, Faculté de Médecine, Université Laval, Québec, Canada,1
Central Laboratory School of Public Health, Peking University, Beijing, China,2
Centro Internacional de Entreamiento e Investigaciones Médicas, Cali, Colombia3
Received 12 May 2003/
Returned for modification 18 June 2003/
Accepted 7 July 2003
The first line drug against leishmaniasis consists of pentavalent antimony [Sb(V)], but there is general belief that the active form of the metal is the trivalent form [Sb(III)]. In this study, we have quantified the accumulation of Sb(V) and Sb(III) in Leishmania by using inductively coupled plasma mass spectrometry. The accumulation was studied in three Leishmania species at various life stages, sensitive or resistant to antimony. Both Sb(III) and Sb(V) are accumulated in promastigote and amastigote parasites, but through competition experiments with arsenite, we found that the routes of entry of Sb(V) and Sb(III) are likely to differ in Leishmania. The level of accumulation of either Sb(III) or Sb(V), however, was not correlated with the susceptibility of wild-type Leishmania cells to antimony. This suggests that other factors may also be implicated in the mode of action of the drugs. In contrast to metal susceptibility, resistance to Sb(III) correlated well with decreased antimony accumulation. This phenotype was energy dependent and highlights the importance of transport systems in drug resistance of this protozoan parasite.
* Corresponding author. Mailing address: Centre de Recherche en Infectiologie CHUQ, Pavillon CHUL, 2705 Boul. Laurier Sainte-Foy, Québec G1V 4G2, Canada. Phone: (418) 654-2705. Fax: (418) 654-2715. E-mail:
Marc.Ouellette{at}crchul.ulaval.ca.
Antimicrobial Agents and Chemotherapy, October 2003, p. 3073-3079, Vol. 47, No. 10
0066-4804/03/$08.00+0 DOI: 10.1128/AAC.47.10.3073-3079.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Goyeneche-Patino, D. A., Valderrama, L., Walker, J., Saravia, N. G.
(2008). Antimony Resistance and Trypanothione in Experimentally Selected and Clinical Strains of Leishmania panamensis. Antimicrob. Agents Chemother.
52: 4503-4506
[Abstract]
[Full Text]
-
Maharjan, M., Singh, S., Chatterjee, M., Madhubala, R.
(2008). Role of Aquaglyceroporin (AQP1) Gene and Drug Uptake in Antimony-resistant Clinical Isolates of Leishmania donovani. Am J Trop Med Hyg
79: 69-75
[Abstract]
[Full Text]
-
MITTAL, M. K., RAI, S., ASHUTOSH, , RAVINDER, , GUPTA, S., SUNDAR, S., GOYAL, N.
(2007). CHARACTERIZATION OF NATURAL ANTIMONY RESISTANCE IN LEISHMANIA DONOVANI ISOLATES. Am J Trop Med Hyg
76: 681-688
[Abstract]
[Full Text]
-
Wong, I. L. K., Chan, K.-F., Burkett, B. A., Zhao, Y., Chai, Y., Sun, H., Chan, T. H., Chow, L. M. C.
(2007). Flavonoid Dimers as Bivalent Modulators for Pentamidine and Sodium Stiboglucanate Resistance in Leishmania. Antimicrob. Agents Chemother.
51: 930-940
[Abstract]
[Full Text]
-
Ashutosh, , Sundar, S., Goyal, N.
(2007). Molecular mechanisms of antimony resistance in Leishmania. J Med Microbiol
56: 143-153
[Abstract]
[Full Text]
-
Croft, S. L., Sundar, S., Fairlamb, A. H.
(2006). Drug Resistance in Leishmaniasis. Clin. Microbiol. Rev.
19: 111-126
[Abstract]
[Full Text]
-
Decuypere, S., Rijal, S., Yardley, V., De Doncker, S., Laurent, T., Khanal, B., Chappuis, F., Dujardin, J.-C.
(2005). Gene Expression Analysis of the Mechanism of Natural Sb(V) Resistance in Leishmania donovani Isolates from Nepal. Antimicrob. Agents Chemother.
49: 4616-4621
[Abstract]
[Full Text]
-
Holzmuller, P., Sereno, D., Lemesre, J.-L.
(2005). Lower Nitric Oxide Susceptibility of Trivalent Antimony-Resistant Amastigotes of Leishmania infantum. Antimicrob. Agents Chemother.
49: 4406-4409
[Abstract]
[Full Text]
-
El Fadili, K., Messier, N., Leprohon, P., Roy, G., Guimond, C., Trudel, N., Saravia, N. G., Papadopoulou, B., Legare, D., Ouellette, M.
(2005). Role of the ABC Transporter MRPA (PGPA) in Antimony Resistance in Leishmania infantum Axenic and Intracellular Amastigotes. Antimicrob. Agents Chemother.
49: 1988-1993
[Abstract]
[Full Text]
-
Wyllie, S., Cunningham, M. L., Fairlamb, A. H.
(2004). Dual Action of Antimonial Drugs on Thiol Redox Metabolism in the Human Pathogen Leishmania donovani. J. Biol. Chem.
279: 39925-39932
[Abstract]
[Full Text]
-
Gourbal, B., Sonuc, N., Bhattacharjee, H., Legare, D., Sundar, S., Ouellette, M., Rosen, B. P., Mukhopadhyay, R.
(2004). Drug Uptake and Modulation of Drug Resistance in Leishmania by an Aquaglyceroporin. J. Biol. Chem.
279: 31010-31017
[Abstract]
[Full Text]